B. Metzler seel. Sohn & Co’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,178
Closed -$1.25M 734
2023
Q1
$1.25M Buy
100,178
+8,802
+10% +$162K 0.02% 401
2022
Q4
$1.76M Hold
91,376
0.03% 327
2022
Q3
$1.72M Buy
91,376
+1,596
+2% +$32.8K 0.03% 322
2022
Q2
$1.62M Buy
89,780
+20,713
+30% +$336K 0.03% 342
2022
Q1
$1.11M Buy
+69,067
New +$1.24M 0.01% 452

Other funds holding AHCO

B. Metzler seel. Sohn & Co's AHCO Position: Q2 2023 in Review

B. Metzler seel. Sohn & Co sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 100,178 shares — an estimated $1.25M sold.

B. Metzler seel. Sohn & Co first reported a position in AHCO in Q1 2022 and held it in 5 quarters. The position peaked at $1.76M in Q4 2022. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • B. Metzler seel. Sohn & Co reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 100,178 AdaptHealth shares in Q2 2023, an estimated $1.25M.
  • B. Metzler seel. Sohn & Co first reported a position in AdaptHealth in Q1 2022 and held it in 5 quarters.
  • B. Metzler seel. Sohn & Co's AdaptHealth position peaked at $1.76M in Q4 2022.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2023, filed 11 Aug 2023.